• Join
  • Login
  • Contact

Search abstracts

Rational use of pharmacogenetic and pharmacogenomic data in post marketing innovation

  • At: 2004 FIP Congress in New Orleans (USA)
  • Type: Presentation
  • By: DAWSON, Bill (Bionet Ltd, Alton, Hants, United Kingdom)
  • Abstract:

    Many medicines do not work equally well in the total patient population for a given indication. Modern genomic science suggests that this may be a result of variation in specific drug targets where single nucleotide polymorphisms may change responsiveness. In addition, the ability of any species to handle xenobiotics has a genetic basis, which


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses